Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Restoring the dysfunctional endothelium.

Elena Osto1, Giuseppe Coppolino, Massimo Volpe

  • 1Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padova, Italy.

Current Pharmaceutical Design
|April 14, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PCSK5 promotes angiogenesis and cardiac repair after myocardial infarction.

Nature communications·2026
Same author

Bile acids: New regulators of the cardiometabolic crosstalk.

Pharmacological research·2026
Same author

Impact of ovarian preservation on survival for premenopausal women with early-stage endometrial carcinoma: A systematic review and meta-analysis.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

Prolonged conservative treatment of women with atypical endometrial hyperplasia and early endometrial carcinoma: A systematic review and meta-analysis.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways.

Circulation·2026
Same author

LTBP4 deficiency inhibits NLRP3 inflammasome activation in cardiomyocytes and attenuates heart failure in male mice.

Nature communications·2026

Endothelial dysfunction is linked to cardiovascular events. Medications like statins and ACE-inhibitors may improve endothelial function, offering potential benefits for managing acute coronary syndromes.

Area of Science:

  • Cardiovascular Medicine
  • Endothelial Biology
  • Pharmacology

Background:

  • The endothelium plays a crucial role in maintaining vascular health, with nitric oxide (NO) mediating key protective effects.
  • Endothelial dysfunction is increasingly recognized as a significant factor in cardiovascular events, including acute coronary syndromes (ACS).
  • Despite advances, cardiovascular disease incidence and complications continue to rise, highlighting the need for improved therapeutic strategies.

Purpose of the Study:

  • To review the role of endothelial dysfunction in acute coronary syndromes.
  • To explore the mechanisms underlying endothelial dysfunction, including oxidative stress.
  • To examine the potential benefits of pharmacological agents on endothelial function in ACS management.

Main Methods:

Related Experiment Videos

  • Literature review focusing on endothelial function, cardiovascular events, and pharmacological interventions.
  • Analysis of current evidence on the interplay between endothelial dysfunction, inflammation, and thrombosis in ACS.
  • Evaluation of the impact of statins, ACE-inhibitors, and angiotensin receptor antagonists on endothelial health.

Main Results:

  • Nitric oxide (NO) is a key mediator of endothelial protective functions.
  • Endothelial dysfunction is associated with increased cardiovascular events and ACS.
  • Statins, ACE-inhibitors, and angiotensin receptor antagonists demonstrate efficacy in improving endothelial function.

Conclusions:

  • Understanding endothelial dysfunction mechanisms, like oxidative stress regulation, is vital for novel therapeutic development.
  • Pharmacological agents such as statins and ACE-inhibitors show promise for improving endothelial function in ACS.
  • These medications may offer significant benefits in the management of acute coronary syndromes by targeting endothelial health.